Fundamental Analysis
70 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +82.4% | +17.5% | 2 / 3 | +20.7% | +8.01 pp | +7.76 pp | +11.2% | 0.77 | 14.40 | 90,2 | +20,7% | 20,7 | +82,4% | 14.40 | 16.48 | −12,6% |
| Pts | 12 | 0 | 8 | 12 | 12 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 17.500 (close price on 2026-10-19)EPS (TTM): 1.215
Financial charts
1.Revenue & growth
VND bn90,2Q2/26
1.Revenue & growth
VND bn90,2Q2/26
2.Profit & growth
VND bn20,7Q2/26
3.Profit mix (Penman)
VND bn53,5Q2/26
4.Margins & cost structure
%28.2%Q2/26
5.Returns & cash cycle
% · days8.9%Q2/26
6.Earnings quality & cash
VND bn106Q2/26
7.Asset structure
VND bn969Q2/26
8.Funding & debt health
VND bn · times969Q2/26
9.Revenue backlog
VND bn0,66Q2/26
10.Valuation
times · %14,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %551Q2/26
Adjusted EPS growth, latest quarter
82.4%
Average adjusted EPS growth, 3 quarters
17.5%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26